SEC Form 4 · accession 0001209191-16-113920
Lineage Cell Therapeutics, Inc. · LCTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael D West
Officer — Co-Chief Executive Officer · Director
Period of report
Apr 7, 2016
Accepted (ET)
Apr 11, 2016 · 9:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000876343
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares, no par valueF1 | holding | — | — | — | 875,987 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common SharesF2 | $3.16 | Apr 7, 2016 | A | 175,000 | A | — | Apr 6, 2026 | Common Shares | 175,000 | 175,000 | D |
| Restricted Stock UnitsF3,F4 | — | Apr 7, 2016 | A | 25,000 | A | — | — | Common Shares | 25,000 | 25,000 | D |
| Option to Purchase Common SharesF5 | $3.51 | holding | — | — | — | — | Jul 9, 2025 | Common Shares | 200,000 | 200,000 | D |
| Option to Purchase Common SharesF6 | $3.51 | holding | — | — | — | — | Mar 19, 2021 | Common Shares | 200,000 | 200,000 | D |
| Option to Purchase Common SharesF7 | $4.22 | holding | — | — | — | — | Feb 19, 2020 | Common Shares | 200,000 | 200,000 | D |
Explanation of responses
- F1Does not include shares that may be acquired upon the exercise of certain stock options.
- F2One quarter of the options shall vest upon the completion of 12 months of continuous employment from the date of grant and the balance shall vest in 36 monthly installments thereafter upon the completion of each month of continuous employment.
- F3Grant of restricted stock units under the BioTime 2012 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one Common Share.
- F4One quarter of the restricted stock units shall vest upon the completion of 12 months of continuous employment from the date of grant and the balance shall vest in twelve equal quarterly installments upon completion of each quarter of continuous employment.
- F5One quarter of the options vested on March 2, 2016 and the balance shall vest in 36 monthly installments thereafter upon the completion of each month of continuous employment.
- F61/48th of the number of options will vest and become exercisable at the end of each full month of employment after March 20, 2014.
- F71/48th of the number of options will vest and become exercisable at the end of each full month of employment after January 1, 2013.